Home > Healthcare > Pharmaceuticals > Finished Drug Form > Blood Platelets Market

Blood Platelets Market Trends

Report ID: GMI2849
Published Date: Sep 2024
Report Format: PDF

Download Free Sample

Blood Platelets Market Trends

The rise in awareness regarding blood donations and platelet transfusions is emerging as a significant trend in the market.

Campaigns and programs, such as World Blood Donor Day, have successfully highlighted the significance of blood and platelet donations. These initiatives are encouraging more voluntary donors, which in turn enhances the supply of platelets for critical medical treatments like surgeries and trauma care.
Additionally, there is a growing emphasis on public education regarding the vital role of platelet transfusions in treating conditions such as cancer, organ transplants, and complex surgeries. This heightened awareness is driving an increased demand for platelets in healthcare settings.
Furthermore, collaborations between healthcare institutions and blood banks are strengthening supply chains, ensuring that platelet transfusions are readily available to patients in need. These developments are contributing to both an increased supply and demand for platelets, thereby driving the overall growth of the market.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Blood platelets market size was USD 5.6 billion in 2023 and is expected to register 4.2% CAGR from 2024-2032 due to the increasing prevalence of chronic and blood-related disorders coupled with growing demand for blood transfusions worldwide.

Blood platelets industry from the apheresis derived platelets segment reached USD 3 billion in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to allowing for the collection of a larger number of platelets from a single donor compared to whole-blood donations.

North America blood platelets industry reached USD 1.5 million in 2023 and is expected to register 2.8% CAGR from 2024-2032 due to significant incidence of blood disorders such as leukemia and lymphoma in the region.

French Red Cross, German Red Cross, Indian Red Cross Society, Italian Red Cross, Japanese Red Cross Society, OneBlood, Red Cross Society of China, South African Red Cross, Spanish Red Cross, and The European Blood Alliance (EBA), are some of the major blood platelets companies worldwide.